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OZONE (O3) is a controversial gas because, owing to its
potent oxidant properties, it exerts damaging effects
on the respiratory tract and yet it has been used for
four  decades  as  a  therapy.  While  the  disinfectant
activity of O3 is understandable, it is less clear how
other  biological  effects  can  be  elicited  in  human
blood with practically no toxicity. On the other hand
plasma  and  cells  are  endowed  with  a  powerful
antioxidant system so that a fairly wide range of O3
concentrations between 40 and 80 m g/ml per gram of
blood  (~0.83–1.66 mM)  are  effective  but  not  delete-
rious. After blood ozonation total antioxidant status
(TAS) and plasma protein thiol groups (PTG) decrease
by  20%  and  25%,  respectively,  while  thiobarbituric
acid reactive substances (TBARS) increases up to five-
fold. The increase of haemolysis is negligible suggest-
ing that the erythrocyte membrane is spared at the
expense of other sacrificial substrates. While there is
a clear relationship between the ozone dose and IL-8
levels, we have noticed that high TAS and PTG values
inhibit the cytokine production. This is in line with
the  current  idea  that  hydrogen  peroxide,  as  a
byproduct of O3 decomposition, acts as a messenger
for the cytokine induction.
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Introduction
In medicine ozone has been used for more than four
decades
1 but  its  application  remains  controversial
mainly  because  ozone  is  potentially  toxic
2 and
mechanisms  of  action  remain  only  partly  known.
3
However, work carried out in our laboratory
3–6 has
contributed  to  clarify  that  ozone  toxicity  can  be
checked if  its concentration,  measured precisely by
ultraviolet  spectrophotometry,  is  not  higher  than
80 m g/ml per gram of blood (~1.76 mM).
Until  recently  it  was  thought  that  human  blood
should  not  be  exposed  to  ozone  concentrations
higher than 35–40 m g/ml of gas (O2 + O3) per gram of
blood.
1 This  was  stated  without  any  experimental
basis  and  as  our  preliminary  work  has  shown,
haemolysis, as a simple marker of erythrocytic dam-
age, becomes progressively relevant only when ozone
concentration  rises  above  90 m g/ml  per  gram
blood.
3
Ozonated  autohaemotherapy  (O3 –  AHT)  is  a
complementary medical  procedure firstly  described
by Wehrli and Steinbart,
7 and since 1954 it has been
used in  millions of patients in different  pathologies
with  apparent clinical benefit.  Simply, it  consists of
briefly  exposing  blood  collected  in  a  disposable
autotransfusion  glass  bottle  to  O2 +  O3 where  the
latter  gas  represents  at  most  4%  of  the  gaseous
mixture. The ozonated blood is thereafter reinfused
into the donor without side effects.
We  believe  that  if  O3 –  AHT  has  to  become  a
relevant  complementary  therapy,  we  must  define
precisely the ozone therapeutic window in order to
improve  effectiveness  and  minimize  toxicity.  O3,
being  a  very  reactive  gas,  could  be  detrimental  to
blood  cells  if  plasma  did  not  possess  an  important
antioxidant capability. O3, when dissolves in plasma,
generates a cascade of reactive oxygen species (ROS),
among which hydrogen peroxide (H2O2),
2 not dissim-
ilar from the constant production of ROS occurring in
physiological conditions.
8 It has been well established
that animal plasmas are usually able to neutralize the
damaging action of ROS by a powerful and articulate
antioxidant  system  composed  of  soluble  com-
pounds,
9–11 protein  thyol  groups,  namely  albu-
min,
12–14 other proteinaceous chelators and three key
enzymes.
15
The  question  arises,  how  effective  is  the  anti-
oxidant  system of human  blood  in  taming O3 reac-
tivity? To answer this question we have now evaluated
critical biochemical parameters in  order to monitor
their modification when blood is exposed to different
O3 concentrations.  Moreover  we  have  investigated
whether exposure of blood to O3 for 1 min is able to
induce any cytokines. By using different experimental
conditions, we have previously shown show that O3,
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interferon (IFN-g )
16 and tumour necrosis factor (TNF-
a ).
17 In line with previous data,
18,19 we report now
that O3 can induce the release of significant amounts
of interleukin (IL-8) from normal human blood.
Materials and methods
Blood samples
Blood samples were taken from healthy male blood
donors  in  the  morning  at  the  Blood  Bank  of  Siena
University. The donors were aged between 22 and 63
years  (mean  38±20  years)  and  they  gave  informed
consent  to  participate  in  the  study.  Calciheparin
(30 U/ml  blood)  was  used  as  an  anticoagulant  and
blood  samples  were  tested  within  an  hour.  Each
sample  was  divided  into  four aliquots  (usually 5 ml
each): the first aliquot was used for assessing baseline
values, while equal volumes of either pure medical
O2, or O2–O3 (O3 concentration 40 m g/ml) or O2–O3
(80 m g/ml/per  gram  of  blood)  were  added  to  the
second,  third  and  fourth  aliquot,  respectively. After
trying  several  procedures,  we  found  that  rapid
rotation of the syringe (filled half with blood and half
with gas) along its longitudinal axis (about 80 cycles/
min) achieved the best mixing with minimal foaming.
After 1 min, the blood was recovered free of gas and
was used for the following determinations.
Biochemical determinations
(a) Total antioxidant status (TAS) in plasma samples
was  carried  out  according  to  Rice-Evans  and
Miller.
20
(b) Protein  thiol  groups  (PTG)  were  measured  in
plasma according to Hu
21 using procedure 1 with
5,59 -dithio-bis(2-nitrobenzoic  acid)  (DTNB)  dis-
solved in absolute methanol.
(c) The thiobarbituric acid (TBA) assay  was carried
out in  plasma as described by Buege and Aust’s
method.
22 Values  (mM)  are  reported  as  TBA
reactive substances.
(d) The haemoglobin determination was carried out
using 20 m l of original blood and an equal volume
of plasma collected after the ozonation. Samples
were mixed with 5 ml of the cyanide-methahae-
moglobin  reagent  (Sclavo  Hemoglobin  test  kit).
Optical  density,  read  spectrophotometrically  at
540 nm, was converted to haemoglobin according
to  a  standard  curve  and  referred  to  as  a  per-
centage of total haemoglobin.
Determination of cytokines
After  the  addition  of  a  sterile  glucose  solution  to
achieve a glucose plasma concentration  of 8–9 mM,
aliquots of all blood samples were layered on sterile
tissue  culture  wells  that  were  incubated  in  air-CO2
(5%) for 8 hours. After centrifugation plasma samples
were kept at –70°C until determinations of cytokines
were carried out. Immunoassays of IL-8, IL-4 and IFNg
were carried out using Cytoscreen immunoassay kits
produced  by  Biosource  Intern.  All  plasma  samples
were diluted 1:1 with the appropriate diluent. A three-
cycle  automatic  washing  was  routinely  performed.
Negative plasma samples, in the absence or presence
of  haemoglobin,  were  spiked  with  the  cytokine’s
standards to assess the reliability and precision of the
various  assays.  Yields  ranged  between  93%  and
105%.
Statistical analyses
Results were expressed as the mean ± SD and the data
were analysed using the Student’s t-test. A P value less
than 0.01 was considered significant.
Results
In preliminary experiments we explored whether TAS
concentration varied after mixing the blood and gas
phases.  Rapid  rotation  of  the  syringe  achieved  the
lowest decrease within 1 min after gas exposure. An
unexpected  finding  was  that  TAS  levels  recovered
very quickly in blood and not in the plasma obtained
from the same blood sample (Fig. 1). This results may
be  explained  by  our  previous  finding
23 that  in
ozonated  plasma  there  is  a  rapid  and  progressive
increase of H2O2 in plasma (up to about 28mM) while
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FIG. 1. Kinetics of total antioxidant levels in human plasma
and blood after exposure at 0 time for 1min of either O2 (O),
or  O3 (40m g/ml)  (m )  or  O3 (80m g/ml)  (d ).  Upper  level
diagram: average of two experiments. Lower level diagram:
mean ± SD of four experiments. *Significant difference (P <
0.01) compared with control.it is hardly detectable in whole blood. Both TAS and
PTG  concentrations  decrease  after  O3 exposure
although the highest O3 concentration (80 m g/ml/per
gram  of  blood)  causes  only  either  20%  or  25%
decrease,  respectively  (Fig.  2).  Conversely,  TBARS
levels and haemoglobin in plasma increased although
the latter was barely perceptible (Fig. 3). Incubation
of ozonated blood allowed the release of significant
amounts of IL-8 (Fig. 4), whereas only negligible levels
of IFN-g and IL-4 were detected. Figure 4 shows that
in two blood samples (donors no. 3 and no. 12) IL-8
has not been induced at all. It is furthermore evident
that increasing the O3 concentration  from 40 m g/ml
up  to  80 m g/ml  markedly  enhances  IL-8  release.
Interestingly donors no. 3 and no. 12 had the highest
TAS levels of all (1.8 and 1.9 mM, respectively). Donor
no. 12 also had the highest levels of PTG (0.54 mM).
It appears therefore that a high level of antioxidants,
by  inhibiting the formation  of H2O2, seems able to
quench the oxidant activity of O3.
Discussion
The  great  reactivity  of  O3 and  its  inherent  toxicity
for  biological  structures  has  become  orthodoxy  in
medicine.
2,24 There  are  however  two  aspects  that
should not be overlooked: firstly, cells and organisms
are  endowed  with  a  powerful  and  articulate  anti-
oxidant  system
8–15 that  may  normally  check  the
physiological production  of  oxidants; and  secondly,
that some oxidant  molecules such as H2O2 and NO
have  been  recently  recognized  as  crucial  physio-
logical  mediators.
25,26 When  human  blood  is
exposed  to  O3,  this  gas  dissolves  in  the  plasmatic
water  and  reacts  immediately  with  several  bio-
molecules,  mainly  polyunsaturated  fatty  acids  gen-
erating  H2O2 and  an  array  of  lipid  oxidation  prod-
ucts  (LOP).
2,27 Both  H2O2 and  LOP  can  elicit  a
number  of  biological  effects  on  blood  cells  which,
by  displaying  widely  different  functions,  can  also
have  different  medical  effects.  The  fundamental
issues  are  that:  firstly,  O3 concentration  must  be
precisely  known  and  this  is  now  possible  with
modern medical O3 generators; secondly, O3 concen-
tration and gas volume must be accurately dosed in
relation to blood weight; thirdly, that the dose of O3
must  not  be  too  low  because  it  will  be  ineffective
Biological effects of ozone
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FIG. 2. Effect of 1min exposure of either O2 or O3 (40m g/ml)
or O3 (80m g/ml) on total antioxidant status (TAS) and protein
thiol groups (PTG) of 13 blood samples. *Significant differ-
ence (P < 0.01) compared with control.
FIG. 3. Effect of 1min exposure of either O2 or O3 (40m g/ml)
or O3 (80m g/ml) on thiobarbituric acid reactive substances
(TBARS) and haemolysis of the same 13 blood samples of
Fig.  2.  *Significant  difference  (P <  0.01)  compared  with
control.but not too high because it will be toxic.
3 In other
words, if we know the TAS and TPG levels of a blood
sample, we can deliver an effective and atoxic ozone
dose; if this view is accepted, ozone can be used as
a  real  drug  with  a  definite  therapeutic  window.
Previous results and the data presented here indicate
that  for  most human  blood samples, acceptable O3
concentrations range between  30  and 80 m g/ml per
gram  of  blood.  Lower  O3 concentrations  may  be
almost  totally  quenched  by  the  antioxidant  system
so that  not enough H2O2 is generated to  reach the
threshold level for activating biochemical and immu-
nological pathways.
We have now shown that even a very transient O3
exposure (only 1 min) can allow the release of IL-8.
Like Jaspers et al.,
19 we believe that induction of IL-8
by  O3 is  promoted  by  a  transient  rise  of  H2O2 in
extracellular-cytoplasmic water via  the  activation  of
the nuclear factor (NF)-kB. This interpretation is well
supported by previous data
18 showing inhibition of IL-
8 production in whole blood by ROS scavengers. IL-8 is
known to be an important chemokine able to initiate
the chemotactic gradient that draws leukocytes from
the circulation into tissues. In order to emphasize the
typical double-edged sword activity of O3, it appears
that when O3 acts on the human respiratory tract the
influx  of  inflammatory  cells  into  the  airway  lumen
caused by IL-8 can be detrimental,
19 while reinfusion
of ozonated blood in immunosuppressed patients can
act as a useful adjuvant in chronic viral diseases.
3At the
present  time,  it  remains  unknown  whether  the
ozonated  blood  can  induce  release  of  IL-8  in  vivo
although it appears unlikely as O3-AHT does not cause
side effects. Moreover in our experimental conditions
IL-4 and IFN-g were hardly detectable and this can be
explained by a too short time of incubation as these
cytokines  are  mostly  produced  after  70 h.
28 A  final
remark must be made about the negligible haemolysis
(as a percentage) noticeable after blood exposure to
80 m g/ml O3: if the value due to mechanical stress is
subtracted, oxidation is responsible for less than a 0.5%
increase. This result emphasizes the great protective
role of plasma because unphysiological situations like
those  used  in  the  past,
29,30 exposing  washed  ery-
throcytes  suspended  in  saline  media  to  O3 yielded
considerable haemolysis. The present work has been
instructive because it has convinced us that even if
marker of peroxidation raises four- to five-folds, there is
no indication  that  the  antioxidant  system has been
overwhelmed with a resulting cell damage. Ozonether-
apy has been an empirical complementary procedure
and unfortunately still is in the hands of quacks and of
V. Bocci et al.
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FIG. 4. Effect of 1min exposure of either O2 or O3 (40m g/ml) or O3 (80m g/ml) on the production of IL-8 after 8-h incubation of
the same 13 blood samples of Figs 2 and 3. Average values are reported in the lower panel after subtracting control values.
*Significant difference (P < 0.01) compared with samples treated with O2.inexperienced practitioners with the implication that
it is used either as a placebo or much worse as a toxic
therapy. We  have  now shown  that  simple tests can
make  ozonetherapy  a  reliable,  reproducible  and
probably effective medical procedure.
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